Yury Verlinsky, the Russian emigre who was the first researcher in the United States to perform chorionic villus sampling to detect birth defects and who pioneered the development of pre-implantation genetic diagnosis to detect potential problems before a fertilized egg is implanted in the mother, died of colon cancer July 16 in Chicago. He was 65.

Mr. Verlinsky was somewhat controversial because of his efforts to help the parents of Molly Nash, who suffered from life-threatening Fanconi anemia, conceive a son, Adam, whose umbilical cord cells saved Molly's life. Two years later, in 2002, he helped a mother carrying the gene for early onset Alzheimer's disease conceive a daughter who was free of the gene.

He was criticized for both cases -- in the first instance for, in effect, creating a child to use for spare parts and in the second for assisting the birth of an infant whose mother soon would not be able to take care of her. He defended his actions, arguing that Adam Nash's parents loved him for himself and that the mother with Alzheimer's hoped medical science would be able to alleviate her condition.

Prenatal testing is a relatively recent invention, with geneticists first performing amniocentesis in the late 1950s. In that procedure, fetal cells suspended in amniotic fluid are extracted with a needle and examined -- initially for visible chromosomal abnormalities but now for a range of genetic effects. It is a relatively safe procedure if performed after 16 weeks of gestation, with a risk to the fetus of much less than 1 percent. Performed earlier, however, it can damage limb development.

Advertise with us

In the 1970s, researchers in Europe and the Soviet Union began using a newer technique called chorionic villus sampling, in which they removed chorionic villi -- wisps of tissue from the outside of the placenta where the fetus is developing -- for testing. This tissue has DNA genetically identical to that of the fetus. The risks are about the same as, or slightly greater than, those for amniocentesis, but the test can be performed as early as 10 weeks, when many prospective parents are more comfortable with an abortion.

Mr. Verlinsky learned the technique in the Soviet Union. When he arrived at Michael Reese Hospital in Chicago in 1979, he began performing the procedure, which soon became widely adopted and is now routine for many prospective parents, particularly those with a history of genetic abnormalities or in which the woman is over 35.

In 1990, he established the Reproductive Genetics Institute in Chicago to provide prenatal testing, plowing the profits back into the organization to support research.

A year earlier, Mr. Verlinsky formed the idea for pre-implantation genetic screening. He and others discovered that a single cell could be removed from an early fertilized egg without disturbing subsequent development. That cell can then be used for genetic diagnosis, and researchers are now able to test for more than 100 genetic disorders. That technique was used for both Adam Nash and the Alzheimer's patient.